The FDA expanded the indication for finerenone (Kerendia) in heart failure (HF), drug manufacturer Bayer announced.

In a recent study posted to the medRxiv* preprint server, researchers conducted an umbrella review and meta-analysis of the renin-angiotensin-aldosterone system (RAAS) inhibitors' impact on ...

Inhibition of the Renin Angiotensin Aldosterone System in Black Populations -- Does It or Doesn't It Work? Janice G. Douglas, MD. Disclosures. July 07, 2004. In This Article.

This study examined renin–angiotensin–aldosterone (RAAS) system gene variants for associations with cardiovascular risk factors and outcomes in coronary heart disease. Coronary disease ...

Discontinuing or reducing renin-angiotensin-aldosterone system inhibitor treatment may have negative outcomes for patients with hyperkalemia, but it is a common practice in many clinics, according ...

Women diagnosed with premenstrual symptoms have a slightly increased risk of developing cardiovascular disease later in life.

Current standard of care medications like ACE inhibitors and angiotensin receptor blockers target the renin-angiotensin-aldosterone system (RAAS), but their focus is primarily on the renin ...

Inhibitors of the Renin–Angiotensin–Aldosterone System and Covid-19. 2020-06-18. DOI: 10.1056/NEJMdo005778 Save. Permissions ...